OVERVIEW

When you choose Merit, you can expect clinically proven embolotherapy products, data-backed embolization results, and ongoing customer support.

Our proprietary embolic products are the most studied on the market and allow for efficient and safe delivery with predictable outcomes. To further support your embolization procedures, we provide a broad collection of physician resources to ensure you have the tools you need for success.

PROCEDURES

Target Treatment Through Embolotherapy

Embolotherapy is a minimally invasive technique used to selectively block blood vessels, effectively treating a range of conditions including tumors, vascular malformations, aneurysms, and acute hemorrhage. Performed by interventional radiologists under image guidance, this procedure delivers embolic agents—such as microspheres, coils, or gels—directly to the target site, preserving healthy surrounding tissue.

In oncology, embolotherapy plays a critical role in transarterial chemoembolization (TACE) and radioembolization, where it helps shrink or control tumor growth. For trauma or gastrointestinal bleeding, it provides rapid hemostasis, often eliminating the need for open surgery. With a growing body of evidence supporting its safety, efficacy, and shorter recovery times, embolotherapy continues to expand across clinical disciplines as a cornerstone of modern interventional care.

PRODUCTS

SUPPORT

Find clinical resources, marketing toolkits, patient awareness materials, and more.

Experience Embolotherapy

Uterine Fibroid Embolization

Experience Embolotherapy

Prostatic Artery Embolization

We are available via phone, email, and live chat to answer any questions you may have.

For additional support, please consider setting up a call with your Merit Representative to review in-service videos together to obtain more product knowledge and insights.

Before using any of the products mentioned, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

REFERENCES

  1. Laurent A et al. 1996. “Trisacryl Gelatin Microspheres for Therapeutic Embolization, I: Development and In Vitro Evaluation.” Am J Neuroradial 17, no. 3 (Mar): 533–540. PMID: 8881250.
  2. Bilbao J et al. 2008. “Comparative Study of Four Different Spherical Embolic Particles In an Animal Model: A Morphologic and Histologic Evaluation.” J Vasc Interv Radiol 19, no. 11 (Nov): 1625–1638. PMID: 18823795.
  3. Lee KH et al. 2008. “Distribution of Iron Oxide-Containing Embosphere Particles After Transcatheter Arterial Embolization In an Animal Model of Liver Cancer: Evaluation with MR Imaging and Implication for Therapy. J Vasc Interv Radiol 19, no. 10 (Oct): 1490–1496. PMID: 18755602.
  4. Wang YXJ et al. 2015. “Transcatheter Embolization Therapy in Liver Cancer: An Update of Clinical Evidences.” Chin J Cancer Res 27, no. 2 (Apr): 96–121. PMID: 25937772.
  5. Data on File.